✨ 19 results found - Searched 22026 records in 5ms.
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_sistem-penghitungan-skor-prediksi-diagnosis-jenis-tumor-mediastinum-20240723092214.jpg&width=120)
Tesis
Sistem penghitungan skor prediksi diagnosis jenis tumor mediastinum
2024 | BY Mario Reggynal - Sita Laksmi Andarini - Jamal Zaini - RR Diah Handayani- Scoring System for Prediction of Mediastinal Tumors Types.
- Nomor Panggil T24268fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2FTESIS.jpg.jpg&width=120)
Tesis
Hubungan Ekspresi Protein CD10, BCL6, MUM1, dan Ki67 secara Kuantitatif dengan Event-Free Survival 24 Bulan Pasien Diffuse Large B-Cell Lymphoma yang Mendapatkan Terapi R-CHOP.
2020 | BY Martha Iskandar - Agnes Stephanie Harahapa - Cosphiadi Irawan - Cleopas Martin Rumende- Correlation Between Quantitative Protein Expression of CD10, BCL6, MUM1, and Ki67 with Event-Free Survival at 24 Months in DLBCL Receiving R-CHOP Therapy.
- Nomor Panggil T20456fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_hubungan-antara-ekspresi-protein-myc-dan-bcl2-dengan-respon-kemoterapi-20240205093947.jpg&width=120)
Tesis
Hubungan antara Ekspresi Protein MYC dan BCL2 dengan Respon Kemoterapi dalam 6 Bulan dan Event Free Survival 24Bulan pada Pasien DLBCL yang Diterapi dengan R-CHOP
2024 | BY Muslimah Luhuna- Association between MYC and BCL2 expression in DLBCL patients who respond to therapy in 6 months and 24 months Event Free Survival with immunochemotherapy using RCHOP.
- Nomor Panggil T24077fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_faktor-faktor-prognostik-progression-free-survival-dua-tahun-pada-pasi-20240130150404.jpg&width=120)
Tesis
Faktor-Faktor Prognostik Progression-Free Survival Dua Tahun pada Pasien Limfoma Hodgkin di Rumah Sakit Umum Pusat Nasional Dokter Cipto Mangunkusumo
2023 | BY Muhamad Reza Prabowo - Anna Mira Lubis - WULYO Rajabto- Two Years-Progression-Free Survival Prognostic Factors of Hodgkin’s Lymphoma Patients in dr. Cipto Mangunkusumo National General Hospital.
- Nomor Panggil T23531fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_respons-antibodi-terhadap-vaksin-covid-19-pada-pasien-leukemia-dan-lim-20240125084941.jpg&width=120)
Tesis
Respons Antibodi terhadap Vaksin COVID-19 pada Pasien Leukemia dan Limfoma dan Faktor-faktor yang Memengaruhinya
2024 | BY Muthmainnah - Sukamto Koesnoe - Andhika Rachman - Alvina Widhani- Antibody Response to COVID-19 Vaccine in Patients with Leukemia and Lymphoma and Factors Influencing It.
- Nomor Panggil T24016fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_hubungan-antara-jumlah-monosit-absolut-tumor-associated-macrophage-da-20230815103833.jpg&width=120)
Tesis
Hubungan antara Jumlah Monosit Absolut, Tumor Associated Macrophage dan Tumor Infiltrating Lymphocytes terhadap Event Free Survival 2 Tahun pada Diffuse Large B-Cell Lymphoma yang mendapatkan terapi RCHOP
2023 | BY Faisal Syarifuddin - Anna Mira Lubis - Agnes Stephanie Harahap - Hamzah Shatri- Correlation between Absolute Monocyte Count, TumorAssociated Macrophage and Tumor Infiltrating Lymphocytes to Event Free Survival 2 years in Diffuse Large B-Cell Lymphoma receiving RCHOP therapy.
- Nomor Panggil T23336fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_hitung-jenis-leukosit-sebagai-prediktor-neutropenia-akut-awitan-pertam-20231117101758.jpg&width=120)
Tesis
Hitung Jenis Leukosit sebagai Prediktor Neutropenia Akut Awitan Pertama Pascakemoterapi R-CHOP pada Pasien Diffuse Large B-cell Lymphoma
2019 | BY Griskalia Christine - Lugyanti Sukrisman - Noorwati Sutandyo - Cleopas Martin Rumende- Differential Count of Leukocytes as A Predictor of The First Onset Acute Neutropenia After R-CHOP Chemotherapy in Diffuse Large B-cell Lymphoma Patients.
- Nomor Panggil T19185fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_tingkat-utilisasi-radioterapi-dalam-tatalaksana-leukemia-dan-limfoma-d-20230130103942.jpg&width=120)
Tesis
Tingkat Utilisasi Radioterapi dalam Tatalaksana Leukemia dan Limfoma di Indonesia
2022 | BY Salik Hawariy - Soehartati A. Gondhowiardjo - Gregorius Ben Prajogi - Handoko - Tiara Bunga Mayang Permata- Radiotherapy Utilization Rate in the Treatment of Leukaemia and Lymphoma in Indonesia.
- Nomor Panggil T22523fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_hubungan-ekspresi-biomarker-bcl-10-terhadap-prognosis-pasien-limfoma-n-20230124105150.jpg&width=120)
Tesis
Hubungan Ekspresi Biomarker BCL-10 Terhadap Prognosis Pasien Limfoma Non-Hodgkin Sel B Adneksa Okular di Rumah Sakit Cipto Mangunkusumo
2022 | BY Whisnu Bambang Jatmiko - Joedo Prihartono - Neni Anggraini- Relationship of BCL-10 Biomarker Expression to Prognosis of Ocular Adnexal B Cell Non-Hodgkin Lymphoma Patients at Cipto Mangunkusumo Hospital.
- Nomor Panggil T22492fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_profil-ekspresi-p63-pada-diffuse-large-b-cell-lymphoma-subtipegerminal-20231107085935.jpg&width=120)
Tesis
Profil Ekspresi p63 pada Diffuse Large B-Cell Lymphoma SubtipeGerminal Center B-Cell Like dan Non-Germinal Center B-Cell Like
2018 | BY Maria Angela Putri Maharani - Koesmardi - Maria Francisca Ham- The p63 Expression Profile on Diffuse Large B-cell Lymphoma Germinal Center B-cell Like and Non-Germinal Center B-cell Like Subtypes.
- Nomor Panggil T18493fk